Everest Medicines Announces Inclusion of VELSIPITY® and XERAVA® in China's 2026 National Reimbursement Drug List
SHANGHAI, Nov. 16, 2026 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or the &quo […]
SHANGHAI, Nov. 16, 2026 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or the &quo […]